APA (7th ed.) Citation

Y, K., E, S., K, S., K, F., K, M., A, F., . . . T, Y. (2023). Author's reply: Detailed Causality between Sodium-glucose Cotransporter 2 Inhibitor and Tubulointerstitial Nephritis. Internal medicine (Tokyo, Japan), 62(5), 819. https://doi.org/10.2169/internalmedicine.0341-22

Chicago Style (17th ed.) Citation

Y, Konta, Saito E, Sato K, Furuta K, Miyauchi K, Furukawa A, Sato H, and Yamamoto T. "Author's Reply: Detailed Causality Between Sodium-glucose Cotransporter 2 Inhibitor and Tubulointerstitial Nephritis." Internal Medicine (Tokyo, Japan) 62, no. 5 (2023): 819. https://doi.org/10.2169/internalmedicine.0341-22.

MLA (9th ed.) Citation

Y, Konta, et al. "Author's Reply: Detailed Causality Between Sodium-glucose Cotransporter 2 Inhibitor and Tubulointerstitial Nephritis." Internal Medicine (Tokyo, Japan), vol. 62, no. 5, 2023, p. 819, https://doi.org/10.2169/internalmedicine.0341-22.